The "portait" of hereditary breast cancer

被引:38
作者
Lacroix, M [1 ]
Leclercq, G [1 ]
机构
[1] Free Univ Brussels, Inst Jules Bordet, Lab Jean Claude Heuson Cancerol Mammaire, B-1000 Brussels, Belgium
关键词
basal; BRCA1; BRCA2; BRCAx; estrogen receptor; genotype; hereditary cancer; luminal; phenotype; p53;
D O I
10.1007/s10549-004-2172-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Five to ten per cent of all breast carcinomas are of hereditary origin. Many of them have been associated to mutations in the BRCA1 and BRCA2 susceptibility genes. No "BRCA3" gene has been found to account for the non-BRCA1/BRCA2 breast cancer (BRCAx) families, and BRCAx tumors are increasingly believed to originate from multiple distinct genetic events. Phenotype studies have questioned the existence of specific "portraits" among hereditary breast carcinomas (HBC). They have shown that most BRCA1 tumors have a "basal (epithelial)-like" aspect, while BRCA2 and BRCAx HBC are more heterogeneous. HBC have also been submitted to genetic analyses, notably with the objective of resolving the heterogeneity of BRCAx lesions. The present review aims to summarize recent data on BRCA1, BRCA2, and BRCAx HBC, including hypotheses on the origin of BRCA1 tumors and their paradoxical relations to estrogen-sensitivity.
引用
收藏
页码:297 / 304
页数:8
相关论文
共 79 条
[21]   BRCA1 functions as a breast stem cell regulator [J].
Foulkes, WD .
JOURNAL OF MEDICAL GENETICS, 2004, 41 (01) :1-5
[22]   Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma [J].
Foulkes, WD ;
Metcalfe, K ;
Hanna, W ;
Lynch, HT ;
Ghadirian, P ;
Tung, N ;
Olopade, O ;
Weber, B ;
McLennan, J ;
Olivotto, IA ;
Sun, P ;
Chappuis, PO ;
Bégin, LR ;
Brunet, JS ;
Narod, SA .
CANCER, 2003, 98 (08) :1569-1577
[23]   Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer [J].
Foulkes, WD ;
Stefansson, IM ;
Chappuis, PO ;
Bégin, LR ;
Goffin, JR ;
Wong, N ;
Trudel, M ;
Akslen, LA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (19) :1482-1485
[24]   BRCA1 supports XIST RNA concentration on the inactive X chromosome [J].
Ganesan, S ;
Silver, DP ;
Greenberg, RA ;
Avni, D ;
Drapkin, R ;
Miron, A ;
Mok, SC ;
Randrianarison, V ;
Brodie, S ;
Salstrom, J ;
Rasmussen, TP ;
Klimke, A ;
Marrese, C ;
Marahrens, Y ;
Deng, CX ;
Feunteun, J ;
Livingston, DM .
CELL, 2002, 111 (03) :393-405
[25]   Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer [J].
Goffin, JR ;
Straume, O ;
Chappuis, PO ;
Brunet, JS ;
Bégin, LR ;
Hamel, N ;
Wong, N ;
Akslen, LA ;
Foulkes, WD .
BRITISH JOURNAL OF CANCER, 2003, 89 (06) :1031-1034
[26]  
Greenblatt MS, 2001, CANCER RES, V61, P4092
[27]  
Grushko TA, 2002, CANCER RES, V62, P1481
[28]   The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens [J].
Hall, JM ;
McDonnell, DP .
ENDOCRINOLOGY, 1999, 140 (12) :5566-5578
[29]   Gene-expression profiles in hereditary breast cancer. [J].
Hedenfalk, I ;
Duggan, D ;
Chen, YD ;
Radmacher, M ;
Bittner, M ;
Simon, R ;
Meltzer, P ;
Gusterson, B ;
Esteller, M ;
Kallioniemi, OP ;
Wilfond, B ;
Borg, Å ;
Trent, J ;
Raffeld, M ;
Yakhini, Z ;
Ben-Dor, A ;
Dougherty, E ;
Kononen, J ;
Bubendorf, L ;
Fehrle, W ;
Pittaluga, S ;
Gruvberger, S ;
Loman, N ;
Johannsoson, O ;
Olsson, H ;
Sauter, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (08) :539-548
[30]   Molecular classification of familial non-BRCA1/BRCA2 breast cancer [J].
Hedenfalk, I ;
Ringnér, M ;
Ben-Dor, A ;
Yakhini, Z ;
Chen, Y ;
Chebil, G ;
Ach, R ;
Loman, N ;
Olsson, H ;
Meltzer, P ;
Borg, Å ;
Trent, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) :2532-2537